Literature DB >> 27354282

SLX4-SLX1 Protein-independent Down-regulation of MUS81-EME1 Protein by HIV-1 Viral Protein R (Vpr).

Xiaohong Zhou1, Maria DeLucia1, Jinwoo Ahn2.   

Abstract

Evolutionarily conserved structure-selective endonuclease MUS81 forms a complex with EME1 and further associates with another endonuclease SLX4-SLX1 to form a four-subunit complex of MUS81-EME1-SLX4-SLX1, coordinating distinctive biochemical activities of both endonucleases in DNA repair. Viral protein R (Vpr), a highly conserved accessory protein in primate lentiviruses, was previously reported to bind SLX4 to mediate down-regulation of MUS81. However, the detailed mechanism underlying MUS81 down-regulation is unclear. Here, we report that HIV-1 Vpr down-regulates both MUS81 and its cofactor EME1 by hijacking the host CRL4-DCAF1 E3 ubiquitin ligase. Multiple Vpr variants, from HIV-1 and SIV, down-regulate both MUS81 and EME1. Furthermore, a C-terminally truncated Vpr mutant and point mutants R80A and Q65R, all of which lack G2 arrest activity, are able to down-regulate MUS81-EME1, suggesting that Vpr-induced G2 arrest is not correlated with MUS81-EME1 down-regulation. We also show that neither the interaction of MUS81-EME1 with Vpr nor their down-regulation is dependent on SLX4-SLX1. Together, these data provide new insight on a conserved function of Vpr in a host endonuclease down-regulation.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  E3 ubiquitin ligase; Western blot; human immunodeficiency virus (HIV); proteasome; protein degradation; viral protein

Mesh:

Substances:

Year:  2016        PMID: 27354282      PMCID: PMC5016100          DOI: 10.1074/jbc.M116.721183

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

Review 1.  Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses.

Authors:  Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2010-07-22       Impact factor: 21.023

2.  A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1.

Authors:  Jianping Jin; Emily E Arias; Jing Chen; J Wade Harper; Johannes C Walter
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

Review 3.  Visualization approaches for multidimensional biological image data.

Authors:  Curtis T Rueden; Kevin W Eliceiri
Journal:  Biotechniques       Date:  2007-07       Impact factor: 1.993

4.  HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest.

Authors:  Jean-Philippe Belzile; Jonathan Richard; Nicole Rougeau; Yong Xiao; Eric A Cohen
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

5.  Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1.

Authors:  Erwann Le Rouzic; Aurélie Mousnier; Cecilia Rustum; Françoise Stutz; Einar Hallberg; Catherine Dargemont; Serge Benichou
Journal:  J Biol Chem       Date:  2002-09-12       Impact factor: 5.157

6.  VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription.

Authors:  Kyunghwan Kim; Jin-Man Kim; Joong-Sun Kim; Jongkyu Choi; Yong Suk Lee; Nouri Neamati; Jin Sook Song; Kyu Heo; Woojin An
Journal:  Mol Cell       Date:  2013-10-17       Impact factor: 17.970

7.  Analysis Tool Web Services from the EMBL-EBI.

Authors:  Hamish McWilliam; Weizhong Li; Mahmut Uludag; Silvano Squizzato; Young Mi Park; Nicola Buso; Andrew Peter Cowley; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2013-05-13       Impact factor: 16.971

8.  HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system.

Authors:  Jason L DeHart; Erik S Zimmerman; Orly Ardon; Carlos M R Monteiro-Filho; Enrique R Argañaraz; Vicente Planelles
Journal:  Virol J       Date:  2007-06-08       Impact factor: 4.099

9.  HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.

Authors:  Jean-Philippe Belzile; Ghislaine Duisit; Nicole Rougeau; Johanne Mercier; Andrés Finzi; Eric A Cohen
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823

10.  MUS81-EME2 promotes replication fork restart.

Authors:  Alessandra Pepe; Stephen C West
Journal:  Cell Rep       Date:  2014-05-09       Impact factor: 9.423

View more
  23 in total

1.  Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages.

Authors:  Jay Lubow; Maria C Virgilio; Madeline Merlino; David R Collins; Michael Mashiba; Brian G Peterson; Zana Lukic; Mark M Painter; Francisco Gomez-Rivera; Valeri Terry; Gretchen Zimmerman; Kathleen L Collins
Journal:  Elife       Date:  2020-03-02       Impact factor: 8.140

2.  HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity.

Authors:  Kelly M Marno; Rebecca Pike; Joseph M Gibbons; Wing-Yiu Jason Lee; Christopher E Jones; Babatunji W Ogunkolade; Claire Pardieu; Alexander Bryan; Rebecca Menhua Fu; Gary Warnes; Paul A Rowley; Richard D Sloan; Áine McKnight
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

3.  Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.

Authors:  Hong Wang; Haoran Guo; Jiaming Su; Yajuan Rui; Wenwen Zheng; Wenying Gao; Wenyan Zhang; Zhaolong Li; Guanchen Liu; Richard B Markham; Wei Wei; Xiao-Fang Yu
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

Review 4.  Viral Modulation of the DNA Damage Response and Innate Immunity: Two Sides of the Same Coin.

Authors:  Andrew Lopez; Randilea Nichols Doyle; Carina Sandoval; Karly Nisson; Vivian Yang; Oliver I Fregoso
Journal:  J Mol Biol       Date:  2021-10-22       Impact factor: 6.151

Review 5.  Hijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins.

Authors:  Tanja Seissler; Roland Marquet; Jean-Christophe Paillart
Journal:  Viruses       Date:  2017-10-31       Impact factor: 5.048

Review 6.  The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.

Authors:  María Eugenia González
Journal:  Int J Mol Sci       Date:  2017-01-10       Impact factor: 5.923

7.  Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages.

Authors:  Li Zhao; Shumei Wang; Meng Xu; Yang He; Xiaowei Zhang; Ying Xiong; Hong Sun; Haibo Ding; Wenqing Geng; Hong Shang; Guoxin Liang
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

8.  HIV-1 Vpr protein directly loads helicase-like transcription factor (HLTF) onto the CRL4-DCAF1 E3 ubiquitin ligase.

Authors:  Xiaohong Zhou; Maria DeLucia; Caili Hao; Kasia Hrecka; Christina Monnie; Jacek Skowronski; Jinwoo Ahn
Journal:  J Biol Chem       Date:  2017-10-27       Impact factor: 5.486

9.  Activation of the DNA Damage Response Is a Conserved Function of HIV-1 and HIV-2 Vpr That Is Independent of SLX4 Recruitment.

Authors:  Oliver I Fregoso; Michael Emerman
Journal:  mBio       Date:  2016-09-13       Impact factor: 7.867

10.  HIV-1 Vpr Reprograms CLR4DCAF1 E3 Ubiquitin Ligase to Antagonize Exonuclease 1-Mediated Restriction of HIV-1 Infection.

Authors:  Junpeng Yan; Ming-Chieh Shun; Caili Hao; Yi Zhang; Juan Qian; Kasia Hrecka; Maria DeLucia; Christina Monnie; Jinwoo Ahn; Jacek Skowronski
Journal:  mBio       Date:  2018-10-23       Impact factor: 7.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.